CYP 2.04% 25.0¢ cynata therapeutics limited

deal, page-10

  1. 174 Posts.
    lightbulb Created with Sketch. 85
    GVHD done deal as negotiated years ago. further licensing rights will be announced, based on meeting milestones of planned phase 2 trials. These will be similar terms to GVHD deal i.e. 90 days post results read out... but with larger prices attached. To get first rights to these further indications Fuji buy Another 10% of the company at a premium to a defined VWAP. Fuji then continue to tell the world they are leading the field with little actual fincanial outlay.....

    All IMO , resulting moderate increase in company value as we would only have one signed deal.... thus allowing Fuji the option for a reasonable T/O price during the phase 2 trials if they are liking the result. Or this could all still be in negotiation, thus TH extension could be on the cards....
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
0.005(2.04%)
Mkt cap ! $44.90M
Open High Low Value Volume
24.5¢ 25.5¢ 24.5¢ $5.409K 21.88K

Buyers (Bids)

No. Vol. Price($)
1 20748 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 8119 2
View Market Depth
Last trade - 15.45pm 24/07/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.